ANA Legal Webinar: NAD Discussion with NAD & Davis Wright Tremaine LLP

This event is over.

ANA Webinar: What’s New at NAD with Laura Brett, BBB National Programs’ National Advertising Division & Nancy Felsten, Davis Wright Tremaine LLP

Join us for a conversation with Laura Brett, Vice President, at BBB National Programs’ National Advertising Division and Nancy Felsten, Partner, Davis Wright Tremaine LLP, as they take stock of NAD’s SWIFT and Complex tracks, its partnership with Facebook, recent NAD cases that broke new ground and speculation about the future of self-regulation.

Laura Brett, Vice President & New York Office Leader at BBB National Programs. In her role, she oversees the daily operations of BBB National Programs’ New York Office and leads BBB National Programs’ National Advertising Division (NAD)—the advertising industry’s system of self-regulation founded in 1971 to boost consumer trust in advertising. Ms. Brett began leading NAD in August of 2017 after serving several years as an NAD staff attorney and Assistant Director. She has helped develop NAD’s body of guidance in the evolving area of truthfulness and transparency for advertising in digital media, including the review of the adequacy of disclosures in influencer marketing as well as other digital formats.

Nancy Felsten, Partner, Davis Wright Tremaine LLP, whether vetting product claims or ensuring regulatory compliance, Felsten is guided by both practicalities and the law, which often in this space comes in the form of guidance and not regulation. She leads the firm's advertising, marketing, and promotions practice and this attitude is how DWT approaches the complicated problems of our day. Whether working with advertising agencies, our media and telecommunications clients, or with consumer electronics, FDA-regulated OTC, banking and consumer product companies, we provide a 360-degree practice for any and all kinds of advertising, marketing, and promotions programs. Nancy helps clients create compliant marketing campaigns pursuant to FTC and FDA regulation and guidance, state consumer protection law, rights of privacy and publicity, and other advertising and intellectual property issues.